Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
536
-
Total 13F shares, excl. options
-
71.7M
-
Shares change
-
-89.5K
-
Total reported value, excl. options
-
$25.8B
-
Value change
-
-$143M
-
Put/Call ratio
-
0.98
-
Number of buys
-
244
-
Number of sells
-
-308
-
Price
-
$360.44
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2016
671 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2016.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 536 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.7M shares
of 105M outstanding shares and own 68.27% of the company stock.
Largest 10 shareholders include FMR LLC (8.62M shares), Capital World Investors (7.01M shares), WELLINGTON MANAGEMENT GROUP LLP (6.21M shares), VANGUARD GROUP INC (4.69M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.02M shares), SANDS CAPITAL MANAGEMENT, LLC (3.39M shares), STATE STREET CORP (3.08M shares), BlackRock Fund Advisors (2.21M shares), JENNISON ASSOCIATES LLC (2.05M shares), and BlackRock Institutional Trust Company, N.A. (1.96M shares).
This table shows the top 536 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.